Closure Device News Today

GALWAY, Ireland, November 14, 2023--Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the 100th patient in its PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal® Closure Device System. The U.S. Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval earlier this year to advance the PATCH stu...

The global vascular closure device market is growing at a CAGR of 7.1% from 2022 to 2030.Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to close the small puncture produced in an artery following an angiography. According to our new research study on “Vascular Closure Device Market Size and Forecasts (2020 - 2030), Global and Regional Share...

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Femoral Closure Devices: Market Snapshot" report has been added to ResearchAndMarkets.com's offering. ...

Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "Sternal Closure Systems Market by Product (Closure Devices (Wires, Plate & Screw, Cable, Clips) Bone...

Left atrial appendage closure, also called LAA closure or LAAC, is a minimally invasive medical procedure used to drastically reduce the risk of stroke in...

Concerns about a lack of balanced information provided about left atrial appendage closure procedures on the web pages of top US hospitals have been raised by a new study.

Results from Largest Ever Real-World Evaluation of the MANTA Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve 

Study intends to demonstrate that ultrasound allows for precise deployment and positive positioning of the MANTA vascular closure device 

Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.

(RTTNews) - Medical technologies firm Teleflex Inc. (TFX) announced Wednesday that it received Health Canada approval for the MANTA Vascular Closu...